Joyce K Thompson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joyce K Thompson has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Arti Shukla
Department of Pathology, University of Vermont College of Medicine, 89 Beaumont Avenue, Burlington, VT 05405, USA
2 shared publications - Brooke T. Mossman
Department of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, United States
2 shared publications - Catherine M Westbom
Department of Pathology, University of Vermont, College of Medicine, Burlington, VT 05405, USA
2 shared publications - Maximilian B. MacPherson
Department of Pathology, University of Vermont College of Medicine, 89 Beaumont Avenue, Burlington, VT 05405, USA
2 shared publications - Chad Steele
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
1 shared publication - Harvey I. Pass
Department of Cardiothoracic Surgery, NYU School of Medicine, New York, USA
1 shared publication
Latest Publications
- Open Access
- 20 May 2014
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 11 (1) , 24
Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
Asbestos exposure is related to various diseases including asbestosis and malignant mesothelioma (MM). Among the pathogenic mechanisms proposed by which asbestos can cause diseases involving epithelial and mesothelial cells, the most widely accepted one is the generation of reactive oxygen species and/or depletion of antioxidants like glutathione. It has also been demonstrated that asbestos can induce inflammation, perhaps due to activation of inflammasomes.
- 20 May 2014
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 11 (1) , 24
Open AccessAsbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation
Asbestos exposure is related to various diseases including asbestosis and malignant mesothelioma (MM). Among the pathogenic mechanisms proposed by which asbestos can cause diseases involving epithelial and mesothelial cells, the most widely accepted one is the generation of reactive oxygen species and/or depletion of antioxidants like glutathione. It has also been demonstrated that asbestos can induce inflammation, perhaps due to activation of inflammasomes.
- Open Access
- 13 August 2013
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 10 (1) , 39
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
Background: Pleural fibrosis and malignant mesotheliomas (MM) occur after exposures to pathogenic fibers, yet the mechanisms initiating these diseases are unclear. Results: We document priming and activation of the NLRP3 inflammasome in human mesothelial cells by asbestos and erionite that is causally related to release of IL-1β, IL-6, IL-8, and Vascular Endothelial Growth Factor (VEGF). Transcription and release of these proteins are inhibited in vitro using Anakinra, an IL-1 receptor antagonist that reduces these cytokines in a human peritoneal MM mouse xenograft model. Conclusions: These novel data show that asbestos-induced priming and activation of the NLRP3 inflammasome triggers an autocrine feedback loop modulated via the IL-1 receptor in mesothelial cell type targeted in pleural infection, fibrosis, and carcinogenesis.
- 13 August 2013
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 10 (1) , 39
Open AccessAsbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells
Background: Pleural fibrosis and malignant mesotheliomas (MM) occur after exposures to pathogenic fibers, yet the mechanisms initiating these diseases are unclear. Results: We document priming and activation of the NLRP3 inflammasome in human mesothelial cells by asbestos and erionite that is causally related to release of IL-1β, IL-6, IL-8, and Vascular Endothelial Growth Factor (VEGF). Transcription and release of these proteins are inhibited in vitro using Anakinra, an IL-1 receptor antagonist that reduces these cytokines in a human peritoneal MM mouse xenograft model. Conclusions: These novel data show that asbestos-induced priming and activation of the NLRP3 inflammasome triggers an autocrine feedback loop modulated via the IL-1 receptor in mesothelial cell type targeted in pleural infection, fibrosis, and carcinogenesis.